Reuters - Video

Edition: U.S. | U.K. | IN | CN

Business

Breakingviews: Cautionary tale for Japan M&A in Ranbaxy fail

Sunday, April 06, 2014 - 02:23

April 7 - Daiichi Sankyo is giving up control of Ranbaxy Laboratories to Sun Pharma for $3.2 billion. Breakingviews' Peter Thal Larsen says it serves as a reminder of what can go wrong in overseas ventures.

▲ Hide Transcript

View Transcript

Press CTRL+C (Windows), CMD+C (Mac), or long-press the URL below on your mobile device to copy the code

Breakingviews: Cautionary tale for Japan M&A in Ranbaxy fail

Sunday, April 06, 2014 - 02:23